Stay updated on Safety Study of AFM11 in NHL Clinical Trial
Sign up to get notified when there's something new on the Safety Study of AFM11 in NHL Clinical Trial page.

Latest updates to the Safety Study of AFM11 in NHL Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe page now displays Revision: v3.4.2, replacing Revision: v3.4.1. This is a minor version update and does not change study details or user-facing information.SummaryDifference0.1%

- Check19 days agoChange DetectedRevision notes show a change from v3.4.0 to v3.4.1 with no visible edits to study content or page functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check33 days agoChange DetectedAdded glossary show/hide controls. Updated the QC criteria update label capitalization and metadata, and bumped the revision to v3.4.0.SummaryDifference0.4%

- Check41 days agoChange DetectedThe page footer now displays Revision: v3.3.4, replacing Revision: v3.3.3. This update is limited to a version label and does not affect study details, eligibility criteria, or user interactions.SummaryDifference0.1%

- Check69 days agoChange DetectedLocations now lists Massachusetts as a study site. The HHS Vulnerability Disclosure footer link has been removed, and the page shows revision v3.3.3.SummaryDifference0.2%

- Check91 days agoChange DetectedThe Publications section was updated to indicate automatic population from PubMed by ClinicalTrials.gov with revision v3.3.2. The previous wording about PubMed-listed publications and revision v3.2.0 was removed.SummaryDifference0.1%

Stay in the know with updates to Safety Study of AFM11 in NHL Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety Study of AFM11 in NHL Clinical Trial page.